News

Optimi Health Applauds Health Canada’s Position on Drug Quality and Goods and Manufacturing Practices (GMP) for Psilocybin

“Sets the right tone, right standard, and right policy”: Optimi Health CEO, Bill Ciprick Optimi Health CEO, Bill Ciprick Optimi…

2 years ago

Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

Axsome is committed to providing patients uninterrupted access to Sunosi and advancing research for patients living with sleep disorders Insurance…

2 years ago

Cannabix Technologies Correlates THC in Breath and Blood using Proprietary Sample Collection and Analysis Hardware in Experimental Study

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix Technologies…

2 years ago

Outlook Therapeutics to Participate at the Virtual Investor 2022 CEO Spotlight

Live moderated video webcast on Wednesday, May 11th at 1:00 PM ETISELIN, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Outlook…

2 years ago

QHSLab. Issues Update and Investor Presentation May 2022

  Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio  Addressable…

2 years ago

Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022

LAWRENCEVILLE, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and…

2 years ago

Allogene Therapeutics Named 2022 Bay Area “Best Place to Work” by San Francisco Business Times and Silicon Valley Business Journal

Allogeneic CAR T Pioneer Highest Ranked Bay Area Biotech in the Large Company Category Based on Employee SurveySOUTH SAN FRANCISCO, Calif.,…

2 years ago

Longeveron to Announce First Quarter 2022 Financial Results on May 13, 2022

Live conference call at 8:30 a.m. ESTMIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"),…

2 years ago

Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results

SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and…

2 years ago

CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System

Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) --  CVRx,…

2 years ago